唐人神集团股份有限公司 章 程 二〇二五年四月 | 第一章 | 总 | 则 2 | | | --- | --- | --- | --- | | 第二章 | | 经营宗旨和范围 3 | | | 第三章 | 股 | 份 4 | | | 第一节 | | 股份发行 | 4 | | 第二节 | | 股份增减和回购 | 4 | | 第三节 | | 股份转让 | 6 | | 第四章 | | 股东和股东会 6 | | | 第一节 | | 股东的一般规定 | 6 | | 第二节 | | 控股股东和实际控制人 | 9 | | 第三节 | | 股东会的一般规定 | 10 | | 第四节 | | 股东会的召集 | 13 | | 第五节 | | 股东会的提案与通知 | 14 | | 第六节 | | 股东会的召开 | 16 | | 第七节 | | 股东会的表决和决议 | 18 | | 第五章 | 董事会 | 21 | | | 第一节 | | 董事的一般规定 | 21 | | 第二节 | | 董事会 | 24 | | 第三节 | | 独立董事 | 28 | | 第四节 | | 董事会专门委员会 | 32 | | 第五节 | | 董事会秘书 ...

Business Performance - The company's operating revenue for 2024 was approximately ¥24.34 billion, a decrease of 9.67% compared to ¥26.95 billion in 2023[31]. - The net profit attributable to shareholders for 2024 was approximately ¥355.42 million, a significant increase of 123.29% from a loss of ¥1.53 billion in 2023[31]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was approximately ¥296.79 million, up 119.72% from a loss of ¥1.51 billion in 2023[31]. - The net cash flow from operating activities for 2024 was approximately ¥936.35 million, representing a 74.83% increase from ¥535.58 million in 2023[31]. - The basic earnings per share for 2024 was ¥0.248, a recovery from a loss of ¥1.0916 in 2023, marking a 122.72% improvement[31]. - The total assets at the end of 2024 were approximately ¥17.99 billion, an increase of 5.75% from ¥17.01 billion at the end of 2023[31]. - The net assets attributable to shareholders at the end of 2024 were approximately ¥5.89 billion, up 7.14% from ¥5.50 billion at the end of 2023[31]. - The company achieved operating revenue of CNY 24.343 billion, a year-on-year decrease of 9.67%[45]. - The net profit attributable to shareholders increased by 123.29% to CNY 355 million[45]. - The company reported a total of 4.3362 million pigs sold, representing a year-on-year growth of 16.80%[45]. Cost Management and Efficiency - The company has implemented a comprehensive disease prevention management system and cost management to enhance production efficiency and reduce costs[13]. - The company is enhancing its production processes by utilizing automated feeding and environmental control systems to improve operational efficiency[13]. - The company has adopted a centralized procurement strategy for raw materials to enhance bargaining power and control costs, ensuring a stable supply chain[10]. - The company reduced the cost of weaned piglets by 46.34 yuan per head compared to the previous year, with expectations for further cost reductions through ongoing investments in breeding and disease control[46]. - The company’s cost of pig fattening decreased by CNY 1.59 per kilogram year-on-year[45]. - The total operating costs decreased by 15.27% to 22,208,823.6 million, with feed costs accounting for 63.31% of total operating costs[73]. Market and Product Development - The company is investing in research and development of meat products to address food safety concerns and improve product quality[15]. - The company is expanding its market presence through strategic partnerships and investments in new technologies[6]. - The company is developing the "Xiangxiang Pig" premium fresh brand through technological innovations in nutrition formulation and breeding, promoting it via both online and offline channels[47]. - The company is focusing on optimizing its digital management system to enhance operational efficiency and decision-making capabilities[17]. - The company plans to expand its "company + farmer" model in regions like Hunan, Guangdong, and Guangxi to enhance profitability[45]. - The company is focusing on new product development, with an investment of 3.49 million in the latest quarter for research and development[109]. Financial Management and Fundraising - The company plans not to distribute cash dividends or issue bonus shares for the current period[18]. - The company has established a comprehensive management system that integrates various operational aspects to ensure steady development[61]. - The company has raised a total of RMB 299,999,997.00 from the issuance of 45,454,545 shares at a price of RMB 6.60 per share, with a net amount of RMB 292,991,294.69 after deducting issuance costs[103]. - The company has a remaining balance of 69,195.04 CNY in unused raised funds, which is stored according to relevant regulations[97]. - The company has redirected RMB 32 million from the "Chongqing Xiangda Biotechnology Co., Ltd. Animal Nutrition Biological Feed Research and Production Base Construction Project" to its subsidiary[114]. Governance and Compliance - The company has established a comprehensive governance structure and internal control system, adhering to relevant laws and regulations to enhance operational standards[145]. - The company is committed to maintaining independent operations, fully separating its business and financial activities from its controlling shareholder[146]. - The company has implemented various internal management systems, including major information reporting and investor relations management[145]. - The company held a total of 6 shareholder meetings in 2024, all conducted legally with the presence of a witnessing lawyer[146]. - The company emphasizes the independence of its operations from controlling shareholders in business, assets, personnel, and finance[150]. Research and Development - The company is focusing on digital transformation to reduce overall breeding costs and improve production and health metrics through AI and IoT technologies[60]. - The company has invested in advanced breeding systems and established partnerships with institutions like the Chinese Academy of Sciences to enhance its breeding capabilities[57]. - The company’s R&D personnel increased to 862 in 2024, a growth of 2.50% compared to 841 in 2023[80]. - R&D investment decreased by 23.34% to ¥101,524,602.56 in 2024 from ¥132,429,246.50 in 2023, representing 0.42% of operating revenue[80]. - The company is committed to enhancing its research and development capabilities in animal nutrition and feed production[119]. Employee Management and Training - The total number of employees at the end of the reporting period is 11,805, with 1,137 in the parent company and 10,668 in major subsidiaries[184]. - The training program in 2024 focused on digital transformation, talent development, and practical skills enhancement, with over 3,093 training sessions covering 120,000 participants and a skill qualification rate of 98%[188]. - The company has implemented a stock option incentive plan, with 403 participants eligible for 6,126,520 stock options in the second exercise period and 50 participants eligible for 822,100 stock options in the first reserved exercise period[193]. - The company emphasizes a "learning organization" ecosystem to support high-quality development through continuous training optimization[188]. - The company's compensation policy is based on annual business plans and performance contributions, aiming for external competitiveness and internal fairness[185].

Financial Performance - The company's revenue for Q1 2025 was CNY 5,973,387,459.78, representing a 22.40% increase compared to CNY 4,880,079,621.11 in the same period last year[4]. - The net loss attributable to shareholders decreased by 60.99% to CNY -77,051,603.93 from CNY -197,512,579.11 year-over-year[4]. - The net cash flow from operating activities improved significantly, reaching CNY 123,149,306.93, a 184.58% increase from CNY -145,605,740.39 in the previous year[4]. - Total operating revenue for the current period reached ¥5,973,387,459.78, an increase of 22.4% compared to ¥4,880,079,621.11 in the previous period[23]. - The net profit for the current period was a loss of ¥80,277,338.74, an improvement from a loss of ¥224,366,712.75 in the previous period[24]. - The total comprehensive income for the period was -80,277,338.74 CNY, compared to -224,366,712.75 CNY in the previous period, indicating an improvement[25]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 18,293,202,363.67, up 1.70% from CNY 17,987,160,209.45 at the end of the previous year[5]. - Current liabilities totaled ¥6,755,703,894.79, an increase from ¥6,257,475,895.75 in the prior period[21]. - Non-current liabilities decreased to ¥5,084,654,087.48 from ¥5,137,678,735.45 in the previous period[21]. - The company's total liabilities increased, with notes payable rising by 36.97% to CNY 740,702,044.00 due to increased procurement[9]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 80,593, with the largest shareholder holding 11.24% of the shares[12]. - The company repurchased 5,617,400 shares, accounting for 0.39% of the total share capital, with a total transaction amount of CNY 28,998,197, at a price range between CNY 4.87 and CNY 5.52 per share[15]. - The company has no significant changes in the shareholding structure of the top 10 shareholders due to margin trading activities[14]. Cash Flow - As of March 31, 2025, the company's cash and cash equivalents amounted to CNY 2,373,528,116.93, an increase from CNY 2,304,501,756.88 at the beginning of the period, reflecting a growth of approximately 2.9%[19]. - Cash inflow from operating activities was 6,376,263,024.95 CNY, up from 5,015,017,110.45 CNY in the previous period, representing a 27.1% increase[26]. - Cash inflow from investment activities was 675,633,594.88 CNY, compared to 351,441,175.68 CNY in the previous period, showing a 92.2% increase[27]. - The ending cash and cash equivalents balance was 2,087,037,485.40 CNY, down from 2,221,986,906.27 CNY in the previous period[27]. Operational Insights - The company reported a significant decrease in other income, down 41.10% to CNY 7,017,649.89, primarily due to reduced government subsidies[11]. - The company experienced a 68.82% reduction in asset disposal gains, reporting CNY -6,808,434.07 compared to CNY -21,834,638.72 in the previous year[11]. - The company's accounts receivable increased to CNY 333,888,202.28 from CNY 281,807,300.66, representing a growth of about 18.5%[19]. - The company's trading financial assets increased to CNY 22,255,080.61 from CNY 16,817,462.12, indicating a growth of about 32.5%[19]. - Research and development expenses were ¥31,638,376.28, a decrease from ¥44,890,002.39 in the previous period[24]. - The company reported an investment income of ¥5,724,708.16, significantly higher than ¥2,292,807.37 in the previous period[24]. Strategic Developments - The company has not disclosed any new product developments or market expansion strategies in the current report[14]. - The company is not currently engaged in any mergers or acquisitions as per the latest financial report[14]. - There are no significant changes in the company's operational strategies mentioned in the earnings call[14]. - The company's weighted average return on equity improved to -1.32% from -3.66% year-over-year[4]. - The company's basic and diluted earnings per share improved by 60.99%, both standing at CNY -0.0538 compared to CNY -0.1379 in the same period last year[4]. Audit Status - The company’s first quarter report was not audited[29].

Investment Rating - The report maintains a "Recommended" investment rating for the industry, suggesting a potential upside of over 15% relative to benchmark indices [4]. Core Insights - The swine industry shows stable breeding profits, with a focus on capacity reduction logic. The average price of external three yuan pigs was 15.0 CNY/kg, up 2.1% week-on-week, while the average weight of pigs sold was 128.6 kg, down 0.2% [19][20]. - The beef industry is at an inflection point, with strong price performance continuing. The average price of calves was 28.2 CNY/kg, up 2.1%, and the average price of fattened cattle was 25.8 CNY/kg, up 0.7% [23][30]. - The white chicken market is affected by ongoing avian influenza, with significant impacts on breeding stock and prices. The average price of white feather broiler chicks was 2.8 CNY/chick, up 9.5% [31][34]. - The animal health sector is seeing a recovery in demand as breeding supply stabilizes, with a notable increase in the issuance of vaccines [48][49]. Summary by Sections Swine Industry - The average price of external three yuan pigs was 15.0 CNY/kg, reflecting a week-on-week increase of 2.1%. The average weight of pigs sold was 128.6 kg, down 0.2%. The price of 15 kg external three yuan piglets was 668 CNY/head, with a slight decrease of 0.05% [19][21]. - Supply pressure remains stable, with normal sales rhythms from large producers and limited sales from smallholders. The demand side shows increased activity from secondary breeding, but overall consumption remains weak [20][21]. - The report recommends companies such as Muyuan Foods, Wens Foodstuff Group, and New Hope Liuhe for investment [20]. Beef Industry - The beef breeding industry is entering a capacity release phase, with the earliest signs of a price bottom forming. The report anticipates a potential recovery in the industry by late 2025 or early 2026 [23][30]. - The average wholesale price of beef was 61.4 CNY/kg, reflecting a slight increase of 0.2% [29][30]. - Recommended companies include Fucheng Co. and Guangming Meat Industry, focusing on integrated breeding and sales [23]. Poultry Industry - The average price of white feather broiler eggs was 1.6 CNY/egg, up 2.0%, while the average price of white feather broilers was 3.7 CNY/kg, up 2.2% [31][34]. - The report highlights the impact of avian influenza on breeding imports, particularly from the U.S. and New Zealand, which has been suspended for over three months [31][32]. - Recommended companies include Yisheng Livestock and He Feng Food [31]. Animal Health Sector - The demand for animal health products is expected to recover as breeding supply stabilizes. The issuance of vaccines has shown significant increases, particularly for swine diseases [48][49]. - The report recommends companies like Kexin Biological and Zhongmu Biotechnology, which are positioned to benefit from the recovery in the animal health market [49].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002567 证券简称：唐人神 公告编号：2025-028 唐人神集团股份有限公司 关于子公司参与投资产业基金合伙企业的进展公告 统一社会信用代码：91440101MA5A3EJQ33 名称：广州大消费品壹期产业投资基金合伙企业（有限合伙） 类型：有限合伙企业 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 唐人神集团股份有限公司（以下简称"公司"）于2017年11月24日召开了第七届董事会第二十六次会议， 审议通过了《关于子公司参与投资产业基金合伙企业的议案》，同意全资子公司深圳前海唐人神投资有 限公司（以下简称"前海唐人神"）作为有限合伙人以自有资金50,000,000元投资广州大消费品壹期产业 投资基金合伙企业（有限合伙）（以下简称"大消费品基金"）。大消费品基金历次变更情况详见公司刊 登在巨潮资讯网（www.cninfo.com.cn）的《关于子公司参与投资产业基金合伙企业的进展公告》。 2025年3月10日，大消费品基金召开合伙人会议，决议：大消费品基金认缴出资额由200,000,000元减 ...

证券代码：002567 证券简称：唐人神 公告编号：2025-027 唐人神集团股份有限公司 关于第三期员工持股计划 第一个锁定期届满的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 唐人神集团股份有限公司（以下简称"公司"、"唐人神"）分别于 2024 年 3 月 6 日、2024 年 3 月 26 日召开第九届董事会第二十三次会议、2024 年第二 次临时股东大会，审议通过了《关于<第三期员工持股计划（草案）>及摘要的议 案》、《关于<第三期员工持股计划管理办法>的议案》、《关于提请股东大会授 权董事会办理公司第三期员工持股计划相关事宜的议案》。鉴于公司第三期员工 持股计划第一个锁定期于 2025 年 4 月 11 日届满，根据中国证券监督管理委员会 《关于上市公司实施员工持股计划试点的指导意见》及《深圳证券交易所上市公 司自律监管指引第 1 号-主板上市公司规范运作》相关规定，现将第三期员工持 股计划第一个锁定期届满后的相关情况公告如下： 一、本次员工持股计划持股情况和锁定期 （一）本次员工持股计划持股初始情况 本次员工持股计划的股票来源为公司回购 ...

Group 1 - The poultry concept sector experienced a decline of 3.89%, ranking among the top losers in the market, with notable declines in companies such as Xiaoming Co., Xiangjia Co., and Huaying Agriculture [1] - The top gaining sectors included automotive chips with a rise of 6.04%, while the top losing sectors included genetically modified crops down by 5.96% and corn down by 5.84% [1] - The poultry sector saw a net outflow of 656 million yuan from major funds, with 21 stocks experiencing outflows, and 8 stocks seeing outflows exceeding 30 million yuan [1] Group 2 - The stock with the highest net outflow was Juxing Agriculture, with a net outflow of 116 million yuan, followed by Wens Foodstuffs and Tiankang Biological with outflows of 111 million yuan and 55.98 million yuan respectively [1] - Other companies in the poultry sector that faced significant net outflows included Tangrenshen, Lihua Co., and Yisheng Co. [1][2] - On the contrary, Yike Food and Chunxue Food were among the few stocks that saw net inflows, with 2.23 million yuan and 14,100 yuan respectively [1]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002567 证券简称：唐人神 公告编号：2025-026 唐人神集团股份有限公司 2025年3月生猪销售简报 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 一、生猪销售情况 2025年3月公司生猪销量同比增长的主要原因是"公司+农户"养殖模式的生猪出栏量增加。 三、风险提示 （一）上述披露仅包含公司生猪养殖业务销售情况，不含饲料、肉品等业务情况。 （二）生猪市场价格波动的风险是整个生猪生产行业的系统风险，对任何一家生猪生产者来说，都是客 观存在的、不可控制的外部风险。生猪市场价格的大幅波动（下降或上升），都可能会对公司的经营业 绩产生较大影响。 四、其他提示 唐人神集团股份有限公司（以下简称"公司"）2025年3月生猪销量40.49万头（其中商品猪38.02万头，仔 猪2.47万头），2024年3月生猪销量34.68万头（其中商品猪28.9万头，仔猪5.78万头），同比上升 16.75%，环比上升1.63%；销售收入合计68,678万元，同比上升32.31%，环比上升0.90%。 2025年1-3 ...

Core Viewpoint - The poultry sector is experiencing a significant surge, with various companies in the chicken industry showing strong performance and potential for growth due to favorable market conditions and recovery in poultry prices. Company Summaries - **Xiangjia Co., Ltd. (002982.SZ)**: Current price is 25.81 CNY, with a three-day consecutive increase of 10.02%. The company has a market capitalization of 2.39 billion CNY and is a leader in the yellow feathered chicken industry, covering breeding, farming, slaughtering, and fresh poultry sales. A strong trading volume of 30.22% indicates active speculation in the market, with a turnaround in profitability and a bullish technical pattern reinforcing upward momentum [1]. - **Huaying Agriculture (002321.SZ)**: Current price is 2.77 CNY, with a first limit-up of 9.92%. The market capitalization stands at 5.88 billion CNY. The company has eight major chicken farms with ongoing capacity release, and net inflow from institutional investors exceeded 50 million CNY. A moderate turnover rate of 6.84% suggests that its low price is attracting risk-averse capital, with recovering poultry prices providing room for valuation recovery [2]. - **Juxing Agriculture (603477.SS)**: Current price is 23.10 CNY, with a first limit-up of 10.00%. The market capitalization is 11.78 billion CNY. This integrated feed and farming enterprise has over 40% of its business in yellow feathered chickens. A turnover rate of 11.43%, along with rising volume and price, indicates strong market interest, and the spillover effect from the pig farming sector is notable [3]. - **Yisheng Livestock (002458.SZ)**: Current price is 10.34 CNY, with a first limit-up of 10.00%. The market capitalization is 7.74 billion CNY. The company is a dominant player in white feathered chicken breeding, with its proprietary "Yisheng 909" variety breaking international monopolies. A stable turnover rate of 9.10% reflects institutional investment interest, and the limited introduction of grandparent stock enhances the premium pricing ability of its seedlings [4]. - **Tangrenshen (002567.SZ)**: Current price is 5.27 CNY, with a first limit-up of 10.02%. The market capitalization is 7.54 billion CNY. The company controls the chicken seed supply chain in Hunan through Jitai Agriculture, with a high turnover rate of 14.40% indicating accelerated expectations of profitability recovery. The decline in feed costs combined with rising chicken prices creates a dual positive effect [5]. - **Ronioushan (000735.SZ)**: Current price is 6.49 CNY, with a first limit-up of 10.00%. The market capitalization is 7.47 billion CNY. The company operates the entire value chain for Wenchang chicken, with a moderate turnover rate of 9.59% highlighting the rarity of regional specialty breeds. The policy benefits from the Hainan Free Trade Port are aiding the upgrade of high-end poultry consumption [6].